• Cook Medical (Bloomington, Indiana) is introducing six new products in parallel to provide better treatment options to the physicians treating people with some form of peripheral arterial disease (PAD) and other diseases of the circulatory system. These products include new microwires, stents and angioplasty balloons that are integral to Cook's advanced leg therapy program, the industry's broadest line of products engineered specifically to address the dynamic circulation of the iliac, femoral, popliteal and infrapopliteal vascular systems. The company's Approach CTO microwires, the first .014-inch wires designed specifically for crossing chronic total occlusions and extremely tight lesions in the peripheral arteries. The Advance line of balloon dilatation catheters comprises three low-profile balloons (14LP, 18LP, 35LP) that range in size and composition to treat lesions in the peripheral arteries (from the femoral through the popliteal and into the infrapopliteal region). Each balloon features a low crossing profile and small-sheath compatibility, which helps reduce the need for an invasive arterial entry and may shorten patient recovery time. Used as an adjunct to percutaneous transluminal angioplasty in the iliac, the Zilver 518 RX is a self-expanding nitinol stent with rapid exchange capabilities that ensure accuracy.

• Compliance 360 (Atlanta) reported the availability of the Compliance 360 Hitech Privacy Breach Management Solution. This solution from Compliance 360 is used by healthcare providers and health insurance companies as their system of record for managing suspected privacy breaches, facilitating investigations, completing timely notifications of affected parties and maintaining an audit-ready state as required by the Health Information Technology for Economic and Clinical Health (HITECH) Act passed as part of the American Recovery and Reinvestment Act of 2009.

• Edwards Lifesciences (Irvine, California) reported results from a new study that demonstrated excellent hemodynamic performance and the absence of any patient-prosthesis mismatch (PPM) in its Carpentier-Edwards Perimount Magna Ease aortic heart valve. PPM has been associated with a significant increase in the risk of overall mortality and cardiac events, and occurs when the replacement valve is too small for the patient's anatomy. The Magna Ease valve includes a low profile and smooth commissure posts to ease insertion through small incisions or small aortic roots. The research team at University Hospital Bern (Switzerland) noted in an editorial that these new features allowed them to implant larger valves to optimize transvalvular flow.